Retatrutide, a novel dual stimulator of the GLP-1 receptor and glucose-dependent insulinotropic polypeptide (GIP) receptor , is showing promising outcomes in preliminary patient studies. Current research https://shopretatrutidepeptide.com/retatrutide-research-knowledge-hub/